First Treatment in 30 Years for Rare Disease Safe, Effective
Subcutaneous efgartigimod PH20 SC is effective and tolerable for the treatment of CIDP, providing a convenient alternative to intravenous and other older treatments.
Stay updated with breaking news from Preventive Screening. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Subcutaneous efgartigimod PH20 SC is effective and tolerable for the treatment of CIDP, providing a convenient alternative to intravenous and other older treatments.
Access to care for the highly preventable disease is thought to be behind why Black Americans are 20% more likely to receive a colorectal cancer diagnosis than any other racial or ethnic group.
Transgender and other gender-diverse youth who visited the emergency department at a single institution had more than five times greater odds of a positive suicide screening.
Children were twice as likely to have three adverse experiences by age 5 if their father had postpartum depression.
Two noninvasive tests in development, one measuring RNA and the other DNA, show high sensitivity for detection of colorectal cancer.